OrthoPediatrics Corp., a leading name in paediatric orthopaedic solutions, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2006, the company has made significant strides in the industry, focusing on the unique needs of children with musculoskeletal conditions. Specialising in innovative surgical solutions, OrthoPediatrics offers a comprehensive range of products, including trauma fixation systems, spinal deformity correction devices, and limb reconstruction tools. Their commitment to advancing paediatric orthopaedics is evident in their unique designs tailored specifically for younger patients. With a strong market position, OrthoPediatrics has garnered recognition for its dedication to improving surgical outcomes and enhancing the quality of life for children worldwide. Their ongoing innovations and strategic partnerships continue to set them apart in the competitive landscape of medical devices.
How does OrthoPediatrics Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
OrthoPediatrics Corp.'s score of 20 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OrthoPediatrics Corp., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. Additionally, the company has not established any reduction targets or climate pledges, which further limits the available information on their climate commitments. As there are no emissions data or reduction initiatives reported, it is unclear how OrthoPediatrics Corp. is addressing climate change within the context of the medical device industry. The lack of transparency in emissions reporting may reflect a broader trend in the sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious sustainability goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OrthoPediatrics Corp. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

